185 related articles for article (PubMed ID: 36480544)
21. Molecular profiling of different glioma specimens from an Ollier disease patient suggests a multifocal disease process in the setting of IDH mosaicism.
Tan CL; Vellayappan B; Wu B; Yeo TT; McLendon RE
Brain Tumor Pathol; 2018 Oct; 35(4):202-208. PubMed ID: 30159860
[TBL] [Abstract][Full Text] [Related]
22. Enchondromatosis: insights on the different subtypes.
Pansuriya TC; Kroon HM; Bovée JV
Int J Clin Exp Pathol; 2010 Jun; 3(6):557-69. PubMed ID: 20661403
[TBL] [Abstract][Full Text] [Related]
23. PTHR1 mutations associated with Ollier disease result in receptor loss of function.
Couvineau A; Wouters V; Bertrand G; Rouyer C; Gérard B; Boon LM; Grandchamp B; Vikkula M; Silve C
Hum Mol Genet; 2008 Sep; 17(18):2766-75. PubMed ID: 18559376
[TBL] [Abstract][Full Text] [Related]
24. An intermediate phenotype in IDH related enchondromatosis spectrum.
Yilmaz-Gulec E; Marzin P; Huber-Lequesne C; Cormier-Daire V
Eur J Med Genet; 2023 Mar; 66(3):104697. PubMed ID: 36649847
[TBL] [Abstract][Full Text] [Related]
25. Cell-free DNA from plasma as a promising alternative for detection of gene mutations in patients with Maffucci syndrome.
Sun Y; Fan X; Rao Y; Wang Z; Wang D; Yang X; Zheng L; Wen M; Cai R; Su L
Hereditas; 2022 Jan; 159(1):4. PubMed ID: 35042566
[TBL] [Abstract][Full Text] [Related]
26. Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C.
Rozeman LB; Sangiorgi L; Briaire-de Bruijn IH; Mainil-Varlet P; Bertoni F; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
Hum Mutat; 2004 Dec; 24(6):466-73. PubMed ID: 15523647
[TBL] [Abstract][Full Text] [Related]
27. Constitutional abnormalities of IDH1 combined with secondary mutations predispose a patient with Maffucci syndrome to acute lymphoblastic leukemia.
Hirabayashi S; Seki M; Hasegawa D; Kato M; Hyakuna N; Shuo T; Kimura S; Yoshida K; Kataoka K; Fujii Y; Shiraishi Y; Chiba K; Tanaka H; Kiyokawa N; Miyano S; Ogawa S; Takita J; Manabe A
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28544751
[TBL] [Abstract][Full Text] [Related]
28. IDH1 Mutation Induces HIF-1
Hu X; Li L; Eid JE; Liu C; Yu J; Yue J; Trent JC
Dis Markers; 2022; 2022():7729968. PubMed ID: 35198082
[TBL] [Abstract][Full Text] [Related]
29. The malignant potential of enchondromatosis.
Schwartz HS; Zimmerman NB; Simon MA; Wroble RR; Millar EA; Bonfiglio M
J Bone Joint Surg Am; 1987 Feb; 69(2):269-74. PubMed ID: 3805090
[TBL] [Abstract][Full Text] [Related]
30.
Chen C; Li J; Jiang T; Tang J; Zhang Z; Luo Y; Wang X; Sun K; Jiang Z; Zhou J; Liu Z
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428825
[TBL] [Abstract][Full Text] [Related]
31. Multifocal intracranial astrocytoma in a pediatric patient with Ollier disease.
Bathla G; Gupta S; Ong CK
Indian J Radiol Imaging; 2012 Jan; 22(1):58-62. PubMed ID: 22623818
[TBL] [Abstract][Full Text] [Related]
32. Recurrent chondrosarcoma of the right skull base in a patient with Maffucci syndrome.
Abdelmalek M; Stanko C
Am J Clin Dermatol; 2008; 9(1):61-5. PubMed ID: 18092846
[TBL] [Abstract][Full Text] [Related]
33. Brain Gliomas and Ollier Disease: Molecular Findings as Predictive Risk Factors?
Corvino S; Mariniello G; Corazzelli G; Franca RA; Del Basso De Caro M; Della Monica R; Chiariotti L; Maiuri F
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884525
[No Abstract] [Full Text] [Related]
34. Loss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome.
Bowen ME; Boyden ED; Holm IA; Campos-Xavier B; Bonafé L; Superti-Furga A; Ikegawa S; Cormier-Daire V; Bovée JV; Pansuriya TC; de Sousa SB; Savarirayan R; Andreucci E; Vikkula M; Garavelli L; Pottinger C; Ogino T; Sakai A; Regazzoni BM; Wuyts W; Sangiorgi L; Pedrini E; Zhu M; Kozakewich HP; Kasser JR; Seidman JG; Kurek KC; Warman ML
PLoS Genet; 2011 Apr; 7(4):e1002050. PubMed ID: 21533187
[TBL] [Abstract][Full Text] [Related]
35. Cancer surveillance in children with Ollier Disease and Maffucci Syndrome.
Diezi M; Zambelli PY; Superti-Furga A; Unger S; Renella R
Am J Med Genet A; 2021 Apr; 185(4):1338-1340. PubMed ID: 33433055
[No Abstract] [Full Text] [Related]
36. Chondrosarcoma of the nasal cavity in a patient with Maffucci syndrome: case report and review of the literature.
Steinbichler TB; Kral F; Reinold S; Riechelmann H
World J Surg Oncol; 2014 Dec; 12():387. PubMed ID: 25519205
[TBL] [Abstract][Full Text] [Related]
37. Insights into Enchondroma, Enchondromatosis and the risk of secondary Chondrosarcoma. Review of the literature with an emphasis on the clinical behaviour, radiology, malignant transformation and the follow up.
Herget GW; Strohm P; Rottenburger C; Kontny U; Krauß T; Bohm J; Sudkamp N; Uhl M
Neoplasma; 2014; 61(4):365-78. PubMed ID: 24645839
[TBL] [Abstract][Full Text] [Related]
38. Deletion 1p in a low-grade chondrosarcoma in a patient with Ollier disease.
Ozisik YY; Meloni AM; Spanier SS; Bush CH; Kingsley KL; Sandberg AA
Cancer Genet Cytogenet; 1998 Sep; 105(2):128-33. PubMed ID: 9723029
[TBL] [Abstract][Full Text] [Related]
39. Genomic Profiling Identifies Association of
Zhu GG; Nafa K; Agaram N; Zehir A; Benayed R; Sadowska J; Borsu L; Kelly C; Tap WD; Fabbri N; Athanasian E; Boland PJ; Healey JH; Berger MF; Ladanyi M; Hameed M
Clin Cancer Res; 2020 Jan; 26(2):419-427. PubMed ID: 31615936
[TBL] [Abstract][Full Text] [Related]
40. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
Rozeman LB; Hameetman L; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Pathol; 2005 Mar; 205(4):476-82. PubMed ID: 15685701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
